Skip to main content
Premium Trial:

Request an Annual Quote

GCI and Celera Diagnostics to Study Rheumatoid Arthritis

NEW YORK, Jan. 16-Genomics Collaborative and Celera Diagnostics will partner to identify the genetics of rheumatoid arthritis, the two companies said today.

 

From its Global Repository specimen database, GCI will provide sample sets from rheumatoid arthritis patients and controls, which Celera Diagnostics will analyze for genetic markers.

 

In the deal, GCI receives an upfront payment and milestone payments on any commercialized products. The companies will share the data generated from these experiments.

 

The companies did not reveal financial specifics.

 

GCI is a functional genomics tool and research company in Cambridge, Mass.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.